TP53 and interstitial lung disease: Intriguingly, pathway analysis of our bulk RNA-seq dataset identified a number of activated pathways which have also been described to be activated in iAEC2 derived from interstitial lung disease patients harbouring mutations in the SFTPC gene, including apoptosis, the p53 pathway, and PI3K-Akt signaling pathway (63).